Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 06, 2015 11:15 PM ET


Company Overview of TNO Triskelion BV

Company Overview

TNO Triskelion BV operates as a contract research organization which offers analysis, toxicology, and chemical risk assessment services. It provides food mapping, nutrient analysis, and biomarker analysis services. The company is based in Zeist, the Netherlands. TNO Triskelion BV operates as a subsidiary of TNO.

Utrechtseweg 48

Zeist,  3704 HE



31 88 866 2800


31 88 866 6970

Key Executives for TNO Triskelion BV

TNO Triskelion BV does not have any Key Executives recorded.

TNO Triskelion BV Key Developments

TNO Triskelion Introduced Bio Safety Level 3

TNO Triskelion announced introduction of a Bio Safety Level 3 (BSL-3) facility and development of special techniques allow to test vaccines against deadly viruses like avian flu and SARS. With this step the contract research organisation responds to a globally growing demand for testing facilities for the development of drugs against these dangerous infectious diseases. It also allows new vaccines against rapidly mutating (avian) influenza viruses reach the public sooner. TNO Triskelion performs research activities for the pharmaceutical, chemical and food industries. The TNO Triskelion facility was recently upgraded to BSL-3 level and accredited by Public Health England (PHE), so that all class 3 viruses and bacteria deadly to humans - from HIV to tuberculosis, from avian influenza to SARS - can be studied in conformity with Good Laboratory Practice (GLP) if required. On a worldwide scale the testing capacity for vaccines against these viruses is extremely limited. The BSL-3 facility will be used for research into avian flu. The Avian Influenza A Virus H7N9 recently appeared in China, taking 40 lives. Virus H5N1 has been active since 1997, H7N7 has made victims since 2008 and recently a woman in China died from H10N8. The viruses spread mostly from animals to man. If avian flu evolves into a virus that transmits from person to person, the threat of a worldwide pandemic is at hand.

Similar Private Companies By Industry

Company Name Region
All-Gen Pharmaceuticals and Generics B.V. Europe
Percuros B.V. Europe
Sanofi-aventis Netherlands B.V. Europe
Synthon Netherlands Holding B.V. Europe
Lead Pharma Holding B.V. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TNO Triskelion BV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at